Yimutian Inc ADRYMT
Price$1.25

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $20.1M0.0% YoYTTM through 31 Dec 2025
Net Income -$6.7MTTM through 31 Dec 2025
Free Cash Flow -$50MTTM through 31 Dec 2025

Margins

Current
Gross Margin84.6%
EBITDA Margin-28.9%
Operating Margin-29.7%
Net Margin-33.2%

Returns

201.3%ROE

Balance Sheet Health

Net Debt$16.1M
Cash & Equivalents$111.1M

Quality Metrics

FCF Margin-248.7%

Dividend

No dividend
Financials converted at 6.9961.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.